Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
A "No Kings" rally isn't just an excuse to take off work while protesting a thing that doesn't exist in America — it's also a great way to find love. Knowing what the chicks at a "No Kings" protest wa...
Many aspects of the US-Israeli aggression look like attempts to fulfil biblical prophecies...
More like LESS Angeles, am I right?...
